The Patent Finder

Adherent Cells from Adipose or Placenta Tissues and Use Thereof in Therapy

Pluri Biotech Ltd.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application PCT/IL2008/001185, filed Sep 2, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,517,248Adherent Cells from Adipose or Placenta Tissues and Use Thereof in Therapy
In force
 · Low confidence
Pluri Biotech Ltd.In force
Low confidence
US 8,529,888Adherent Cells from Adipose or Placenta Tissues and Use Thereof in Therapy
In force
 · High confidence
Pluri Biotech Ltd.In force
High confidence
Application 17/817,488Adherent Cells from Adipose or Placenta Tissues and Use Thereof in Therapy
Abandoned
Abandoned Sep 29, 2025
Pluri Biotech Ltd.AbandonedAbandoned Sep 29, 2025
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Pluri Biotech Ltd..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited